Gilead Rescues CV Therapeutics
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 3 (Table of Contents)
Published: 14 Mar-2009
DOI: 10.3833/pdr.v2009.i3.1078 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Gilead Sciences has agreed to acquire CV Therapeutics (CVT) for US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS